# Black Education and Treatment of Hypertension (BEAT HTN)

> **NCT00661895** · PHASE4 · COMPLETED · sponsor: **Creighton University** · enrollment: 99 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Hydrochlorothiazide
- **DRUG:** Lisinopril
- **DRUG:** Lisinopril and Hydrochlorothiazide
- **DRUG:** Nifedipine XL
- **DRUG:** Metoprolol tartrate
- **DRUG:** Atenolol
- **DRUG:** Valsartan
- **DRUG:** Doxazosin
- **DRUG:** Clonidine
- **DRUG:** Hydralazine
- **DRUG:** Metoprolol succinate
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT00661895
- **Lead sponsor:** Creighton University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2009-08
- **Final completion:** 2009-11
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2012-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00661895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00661895, "Black Education and Treatment of Hypertension (BEAT HTN)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00661895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
